NTRA |
Natera, Inc. |
19.12B |
3.57% |
|
|
|
|
|
141.41 |
-1.76% |
53.42% |
44.60% |
---|
GILD |
Gilead Sciences, Inc. |
139.54B |
2.94% |
|
|
|
|
|
112.05 |
0.23% |
35.65% |
78.34% |
---|
UTHR |
United Therapeutics Corporation |
13.85B |
2.90% |
|
|
|
|
|
308.27 |
0.42% |
35.09% |
86.28% |
---|
INCY |
Incyte Corporation |
11.72B |
2.90% |
|
|
|
|
|
60.55 |
-0.08% |
42.37% |
41.87% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
11.03B |
2.88% |
|
|
|
|
|
110.60 |
-2.26% |
34.71% |
25.33% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
6.19B |
2.69% |
|
|
|
|
|
63.82 |
-9.36% |
60.76% |
26.18% |
---|
INSM |
Insmed Incorporated |
13.81B |
2.60% |
|
|
|
|
|
76.29 |
-2.18% |
46.27% |
4.86% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
124.50B |
2.55% |
|
|
|
|
|
484.82 |
-1.60% |
29.36% |
31.63% |
---|
EXAS |
Exact Sciences Corporation |
8.04B |
2.45% |
|
|
|
|
|
43.29 |
-0.85% |
63.70% |
42.95% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
35.12B |
2.43% |
|
|
|
|
|
270.02 |
0.58% |
41.52% |
28.67% |
---|
ABBV |
AbbVie Inc. |
370.64B |
2.34% |
|
|
|
|
|
209.52 |
2.06% |
32.64% |
87.87% |
---|
MDGL |
Madrigal Pharmaceuticals, Inc. |
7.31B |
2.17% |
|
|
|
|
|
331.23 |
1.02% |
61.15% |
41.88% |
---|
AMGN |
Amgen Inc. |
167.37B |
2.12% |
|
|
|
|
|
311.55 |
1.50% |
34.22% |
40.80% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
13.49B |
2.04% |
|
|
|
|
|
70.69 |
-1.05% |
33.04% |
33.98% |
---|
BIIB |
Biogen Inc. |
20.03B |
2.03% |
|
|
|
|
|
136.84 |
-1.11% |
40.91% |
60.79% |
---|
VKTX |
Viking Therapeutics, Inc. |
2.71B |
1.87% |
|
|
|
|
|
24.15 |
-5.85% |
70.71% |
40.37% |
---|
TGTX |
TG Therapeutics, Inc. |
6.19B |
1.83% |
|
|
|
|
|
39.43 |
-1.08% |
63.46% |
48.89% |
---|
BPMC |
Blueprint Medicines Corporation |
5.66B |
1.74% |
|
|
|
|
|
88.51 |
-0.24% |
66.68% |
39.96% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
68.18B |
1.66% |
|
|
|
|
|
634.23 |
-0.49% |
42.98% |
86.44% |
---|
CYTK |
Cytokinetics, Incorporated |
4.76B |
1.64% |
|
|
|
|
|
40.19 |
-6.95% |
54.27% |
84.24% |
---|
MRNA |
Moderna, Inc. |
10.94B |
1.62% |
|
|
|
|
|
28.35 |
-8.90% |
69.99% |
64.89% |
---|
CRSP |
CRISPR Therapeutics AG |
2.92B |
1.48% |
|
|
|
|
|
34.03 |
-8.00% |
52.17% |
49.24% |
---|
HALO |
Halozyme Therapeutics, Inc. |
7.88B |
1.39% |
|
|
|
|
|
63.81 |
-0.05% |
37.56% |
25.13% |
---|
EXEL |
Exelixis, Inc. |
10.33B |
1.25% |
|
|
|
|
|
36.92 |
0.60% |
35.76% |
38.73% |
---|
ROIV |
Roivant Sciences Ltd. |
7.20B |
1.24% |
|
|
|
|
|
10.09 |
-2.79% |
32.36% |
58.64% |
---|
ALKS |
Alkermes plc |
5.37B |
1.22% |
|
|
|
|
|
33.02 |
-0.57% |
55.46% |
59.42% |
---|
KRYS |
Krystal Biotech, Inc. |
5.19B |
1.20% |
|
|
|
|
|
180.30 |
-1.97% |
46.99% |
40.31% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
4.80B |
1.18% |
|
|
|
|
|
30.17 |
-3.15% |
57.02% |
76.32% |
---|
RVMD |
Revolution Medicines, Inc. |
6.57B |
1.17% |
|
|
|
|
|
35.36 |
-5.33% |
66.81% |
37.66% |
---|
ADMA |
ADMA Biologics, Inc. |
4.71B |
1.16% |
|
|
|
|
|
19.84 |
-2.07% |
61.47% |
23.31% |
---|
APLS |
Apellis Pharmaceuticals, Inc. |
2.75B |
1.07% |
|
|
|
|
|
21.87 |
-9.89% |
43.44% |
23.94% |
---|
BBIO |
BridgeBio Pharma, Inc. |
6.57B |
1.05% |
|
|
|
|
|
34.57 |
-1.54% |
60.00% |
23.10% |
---|
TWST |
Twist Bioscience Corporation |
2.34B |
1.05% |
|
|
|
|
|
39.26 |
-2.73% |
66.71% |
39.71% |
---|
RNA |
Avidity Biosciences, Inc. |
3.55B |
1.04% |
|
|
|
|
|
29.52 |
-6.58% |
67.15% |
27.99% |
---|
PCVX |
Vaxcyte, Inc. |
4.86B |
0.90% |
|
|
|
|
|
37.76 |
-45.64% |
62.20% |
48.05% |
---|
BHVN |
Biohaven Pharmaceutical Holding Company ... |
2.45B |
0.89% |
|
|
|
|
|
24.04 |
-13.06% |
62.50% |
58.16% |
---|
GERN |
Geron Corporation |
1.01B |
0.85% |
|
|
|
|
|
1.5900 |
-3.64% |
92.88% |
86.37% |
---|
BEAM |
Beam Therapeutics Inc. |
1.95B |
0.84% |
|
|
|
|
|
19.53 |
-12.07% |
63.92% |
51.89% |
---|
CRNX |
Crinetics Pharmaceuticals, Inc. |
3.12B |
0.83% |
|
|
|
|
|
33.54 |
-3.43% |
70.01% |
33.86% |
---|
SWTX |
SpringWorks Therapeutics, Inc. |
3.31B |
0.82% |
|
|
|
|
|
44.13 |
-6.92% |
95.98% |
50.64% |
---|
IOVA |
Iovance Biotherapeutics, Inc. |
1.09B |
0.80% |
|
|
|
|
|
3.33 |
-6.46% |
74.66% |
43.14% |
---|
RXRX |
Recursion Pharmaceuticals, Inc. |
2.09B |
0.78% |
|
|
|
|
|
5.29 |
-8.95% |
72.85% |
7.84% |
---|
SRRK |
Scholar Rock Holding Corporation |
3.04B |
0.77% |
|
|
|
|
|
32.15 |
-2.10% |
62.30% |
22.87% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
2.77B |
0.77% |
|
|
|
|
|
16.61 |
-2.69% |
52.38% |
66.94% |
---|
PTCT |
PTC Therapeutics, Inc. |
4.02B |
0.77% |
|
|
|
|
|
50.96 |
-6.05% |
48.14% |
48.63% |
---|
ACLX |
Arcellx, Inc. |
3.60B |
0.73% |
|
|
|
|
|
65.60 |
-3.47% |
46.12% |
31.19% |
---|
RARE |
Ultragenyx Pharmaceutical Inc. |
3.35B |
0.70% |
|
|
|
|
|
36.21 |
-4.26% |
71.90% |
34.14% |
---|
DYN |
Dyne Therapeutics, Inc. |
1.18B |
0.67% |
|
|
|
|
|
10.46 |
-8.65% |
230.48% |
49.37% |
---|
IMVT |
Immunovant, Inc. |
2.90B |
0.66% |
|
|
|
|
|
17.09 |
-6.97% |
77.80% |
28.34% |
---|
JANX |
Janux Therapeutics, Inc. |
1.60B |
0.63% |
|
|
|
|
|
27.00 |
-7.22% |
81.13% |
26.08% |
---|
FOLD |
Amicus Therapeutics, Inc. |
2.51B |
0.63% |
|
|
|
|
|
8.16 |
-3.20% |
51.71% |
70.84% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
1.75B |
0.62% |
|
|
|
|
|
12.74 |
-7.81% |
56.04% |
63.20% |
---|
VCYT |
Veracyte, Inc. |
2.31B |
0.61% |
|
|
|
|
|
29.65 |
-1.56% |
62.23% |
42.54% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
1.68B |
0.60% |
|
|
|
|
|
29.30 |
-3.24% |
67.83% |
42.95% |
---|
ARQT |
Arcutis Biotherapeutics, Inc. |
1.86B |
0.59% |
|
|
|
|
|
15.64 |
-0.57% |
80.40% |
43.07% |
---|
NUVL |
Nuvalent, Inc. |
5.08B |
0.58% |
|
|
|
|
|
70.92 |
-2.92% |
47.10% |
49.00% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.97B |
0.58% |
|
|
|
|
|
48.36 |
-1.06% |
68.70% |
0.08% |
---|
MIRM |
Mirum Pharmaceuticals, Inc. |
2.21B |
0.57% |
|
|
|
|
|
45.05 |
-2.04% |
49.91% |
51.95% |
---|
RYTM |
Rhythm Pharmaceuticals, Inc. |
3.35B |
0.56% |
|
|
|
|
|
52.97 |
-3.34% |
54.39% |
77.63% |
---|
NVAX |
Novavax, Inc. |
1.03B |
0.54% |
|
|
|
|
|
6.41 |
-8.43% |
80.26% |
32.64% |
---|
VERA |
Vera Therapeutics, Inc. |
1.53B |
0.54% |
|
|
|
|
|
24.02 |
-9.80% |
65.71% |
67.43% |
---|
NTLA |
Intellia Therapeutics, Inc. |
736.01M |
0.53% |
|
|
|
|
|
7.11 |
-11.90% |
84.48% |
71.02% |
---|
DVAX |
Dynavax Technologies Corporation |
1.61B |
0.53% |
|
|
|
|
|
12.97 |
-5.19% |
247.79% |
46.95% |
---|
IDYA |
IDEAYA Biosciences, Inc. |
1.43B |
0.51% |
|
|
|
|
|
16.38 |
-3.93% |
142.62% |
66.71% |
---|
ARDX |
Ardelyx, Inc. |
1.17B |
0.50% |
|
|
|
|
|
4.91 |
-0.41% |
88.22% |
48.36% |
---|
VCEL |
Vericel Corporation |
2.24B |
0.47% |
|
|
|
|
|
44.62 |
0.27% |
58.27% |
75.11% |
---|
KYMR |
Kymera Therapeutics, Inc. |
1.78B |
0.44% |
|
|
|
|
|
27.37 |
-7.60% |
67.60% |
109.15% |
---|
BCRX |
BioCryst Pharmaceuticals, Inc. |
1.57B |
0.43% |
|
|
|
|
|
7.50 |
-4.58% |
50.70% |
37.32% |
---|
DNLI |
Denali Therapeutics Inc. |
1.97B |
0.43% |
|
|
|
|
|
13.60 |
-8.02% |
64.25% |
63.21% |
---|
SLNO |
Soleno Therapeutics, Inc. |
3.28B |
0.42% |
|
|
|
|
|
71.45 |
-0.75% |
69.57% |
18.48% |
---|
CPRX |
Catalyst Pharmaceuticals, Inc. |
2.95B |
0.41% |
|
|
|
|
|
24.25 |
-1.78% |
42.34% |
39.32% |
---|
AKRO |
Akero Therapeutics, Inc. |
3.22B |
0.41% |
|
|
|
|
|
40.48 |
-5.24% |
73.43% |
9.72% |
---|
APGE |
Apogee Therapeutics, Inc. |
2.22B |
0.40% |
|
|
|
|
|
37.36 |
-5.94% |
66.75% |
41.84% |
---|
PRAX |
Praxis Precision Medicines, Inc. |
763.58M |
0.40% |
|
|
|
|
|
37.87 |
-2.04% |
167.62% |
18.27% |
---|
IRON |
Disc Medicine, Inc. |
1.72B |
0.38% |
|
|
|
|
|
49.64 |
-5.19% |
76.09% |
30.25% |
---|
CLDX |
Celldex Therapeutics, Inc. |
1.20B |
0.37% |
|
|
|
|
|
18.15 |
-8.93% |
48.11% |
46.12% |
---|
SNDX |
Syndax Pharmaceuticals, Inc. |
1.06B |
0.37% |
|
|
|
|
|
12.29 |
-6.79% |
77.62% |
57.49% |
---|
CGON |
CG Oncology, Inc. Common stock |
1.88B |
0.36% |
|
|
|
|
|
24.49 |
-7.31% |
102.73% |
34.44% |
---|
SMMT |
Summit Therapeutics Inc. |
14.23B |
0.32% |
|
|
|
|
|
19.29 |
-5.07% |
47.52% |
13.25% |
---|
MNKD |
MannKind Corporation |
1.53B |
0.31% |
|
|
|
|
|
5.03 |
0.00% |
67.81% |
39.27% |
---|
VRDN |
Viridian Therapeutics, Inc. |
1.10B |
0.31% |
|
|
|
|
|
13.48 |
-6.65% |
48.83% |
28.09% |
---|
NRIX |
Nurix Therapeutics, Inc. |
901.54M |
0.30% |
|
|
|
|
|
11.88 |
-2.22% |
80.19% |
49.99% |
---|
DAWN |
Day One Biopharmaceuticals, Inc. |
803.75M |
0.27% |
|
|
|
|
|
7.93 |
-1.73% |
62.90% |
33.81% |
---|
SYRE |
Spyre Therapeutics, Inc. |
972.25M |
0.27% |
|
|
|
|
|
16.14 |
-10.06% |
139.55% |
48.66% |
---|
TVTX |
Travere Therapeutics, Inc. |
1.59B |
0.25% |
|
|
|
|
|
17.92 |
-8.94% |
77.53% |
10.32% |
---|
XNCR |
Xencor, Inc. |
749.71M |
0.25% |
|
|
|
|
|
10.64 |
-5.25% |
81.40% |
78.99% |
---|
CDNA |
CareDx, Inc |
983.81M |
0.24% |
|
|
|
|
|
17.75 |
-1.17% |
110.71% |
41.60% |
---|
MYGN |
Myriad Genetics, Inc. |
809.91M |
0.24% |
|
|
|
|
|
8.87 |
-0.11% |
60.35% |
89.28% |
---|
RCKT |
Rocket Pharmaceuticals, Inc. |
711.22M |
0.24% |
|
|
|
|
|
6.67 |
-12.12% |
217.96% |
67.64% |
---|
CDMO |
AVID BIOSERVICES INC |
|
0.22% |
|
|
|
|
|
|
|
|
|
---|
ALT |
Altimmune, Inc. |
385.07M |
0.22% |
|
|
|
|
|
5.00 |
-6.02% |
85.68% |
37.46% |
---|
IBRX |
ImmunityBio, Inc. |
2.57B |
0.22% |
|
|
|
|
|
3.01 |
-4.14% |
162.94% |
31.11% |
---|
RCUS |
Arcus Biosciences, Inc. |
830.85M |
0.22% |
|
|
|
|
|
7.85 |
-3.92% |
286.49% |
44.49% |
---|
IRWD |
Ironwood Pharmaceuticals, Inc. |
235.24M |
0.21% |
|
|
|
|
|
1.4700 |
4.26% |
191.36% |
18.01% |
---|
CGEM |
Cullinan Oncology, Inc. |
442.94M |
0.21% |
|
|
|
|
|
7.57 |
-5.61% |
173.08% |
77.02% |
---|
VIR |
Vir Biotechnology, Inc. |
888.69M |
0.21% |
|
|
|
|
|
6.48 |
-3.28% |
70.90% |
57.81% |
---|
AVXL |
Anavex Life Sciences Corp. |
729.85M |
0.20% |
|
|
|
|
|
8.58 |
-1.61% |
98.87% |
24.97% |
---|
EBS |
Emergent BioSolutions Inc. |
264.08M |
0.20% |
|
|
|
|
|
4.86 |
4.29% |
109.33% |
32.99% |
---|
REPL |
Replimune Group, Inc. |
750.89M |
0.20% |
|
|
|
|
|
9.75 |
-6.16% |
122.01% |
15.10% |
---|
VERV |
Verve Therapeutics, Inc. |
405.80M |
0.18% |
|
|
|
|
|
4.57 |
-12.45% |
154.23% |
92.25% |
---|